Chemical Peel for Skin Rejuvenation - Quick Reference Sheet

Chemical Peel for Skin Rejuvenation

Created on 07/20/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A controlled resurfacing procedure that removes damaged outer skin and prompts the deeper layers to rebuild. Best supported for softening fine lines, rough texture, and uneven skin tone; more modest for acne and firmness; limited for pitted scars. Deeper peels do more but carry greater risk of lasting color change and scarring. (Full Review)

Protocol

Superficial Series
Glycolic 20–70% or salicylic 20–30%
Every 2–4 weeks, 4–6 sessions; for texture, tone, mild pigmentation, acne
Medium-Depth
Jessner's or 70% glycolic followed by 35% TCA
Usually a single treatment; for photoaging, deeper pigmentation, actinic damage
Deep Peel
Phenol-croton oil
Once under monitoring; reserved for lighter skin and significant photoaging
Time to effect
Deep Peel
Months
Full results emerge as redness fades
Medium Peel
2–4 weeks
Improvement after the initial peeling settles
Superficial
Days to weeks
Brief glow in days; tone and acne benefit over a series

Benefits

Contraindications
  • Active infection or open skin (herpes simplex outbreak, impetigo, dermatitis)
  • Very dark skin (Fitzpatrick V–VI) for medium/deep peels
  • History of keloids or hypertrophic scarring
  • Pregnancy and breastfeeding
  • Significant cardiac, hepatic, or renal disease
  • Unrealistic expectations or inability to comply with sun protection and aftercare
Key Interactions
  • Recent oral isotretinoin
  • Photosensitizing medications (tetracyclines such as doxycycline, certain diuretics, retinoids)
  • Topical over-the-counter actives (retinol, benzoyl peroxide, alpha- and beta-hydroxy acid products, scrubs)
  • Supplements with additive skin effects (high-dose vitamin A/retinoid supplements, topical vitamin C or niacinamide)
  • Concurrent procedures (recent laser, microneedling, waxing, or radiation to the area)

Risk & Side Effects

  • High: Post-inflammatory hyperpigmentation; transient redness, burning, flaking, and downtime
  • Medium: Scarring; infection; persistent hypopigmentation and demarcation lines; phenol cardiotoxicity
  • Low: Milia, acne flares, and contact dermatitis; ocular injury and ectropion
  • Speculative: Cumulative skin-barrier disruption from frequent superficial peeling

Monitoring

Marker Target Why
Fitzpatrick Skin Phototype Type I–III Predicts risk of post-peel darkening and guides agent and depth
Glogau Photoaging Class Baseline (class I–IV) Grades sun-damage severity to match peel depth and set realistic goals
12-Lead ECG Normal sinus rhythm Deep phenol peels can trigger arrhythmias via absorbed phenol
Serum Creatinine ~0.6–1.0 mg/dL Phenol is cleared by the kidneys; poor clearance raises toxicity risk
Liver Enzymes (ALT/AST) Under ~25 U/L Phenol is processed by the liver; screens fitness for deep peels
Herpes Simplex (HSV) Status No active lesions Peeling can reactivate and spread cold-sore virus

Cadence: First week after medium and deep peels, again at 2–4 weeks as peeling resolves, then periodically (every few months for a superficial series)

Qualitative Assessment

  • Smoother, softer skin texture and reduced roughness
  • More even skin tone with fading of spots and blotchiness
  • Softening of fine lines and an overall brighter, more refreshed appearance
  • Fewer active acne lesions and less surface oiliness (for acne-focused peels)
  • Personal satisfaction with appearance balanced against acceptable downtime
  • Absence of lingering redness, darkening, or irritation beyond the expected recovery window